Margaret Krackeler, MD, of Kaiser Permanente Northern California, shares lessons on implementing evidence-based formulary changes for patients with CLL.

In this final interview clip, Kenneth Komorny, PharmD, BCPS, of Moffitt Cancer Center, emphasizes that oncology pharmacy is becoming increasingly essential as cancer treatments ev ...

The Orphan Drug Act has boosted treatments, but Kristi Martin, MPA, MA, urges modernizing incentives and pricing to sustain ...

Combined employer premium contributions and deductibles exceeded 10% of median household income in 19 states, ...

Community-academic collaboration can reduce access burdens and strengthen continuity of care, says Anasuya Gunturi, MD, PhD.

Older adults living with heart failure with preserved ejection fraction (HFpEF) are frequently labeled as having chronic ...

A 26% relative hazard reduction in recurrent ischemic stroke was observed (HR 0.74), with primary efficacy assessed as time to first ischemic stroke. OCEANIC-STROKE trial data show asundexian cuts ...

Andrew Yee, MD, is the clinical director of the Center for Multiple Myeloma at Massachusetts General Hospital. Andrew Yee, MD, explains how academic centers can share practical oncology best practices ...

The Consolidated Appropriations Act of 2026 gives CMS more leverage to intercept when pharmacy benefit managers are driving up prices in Medicare Part D, explains Jesse Dresser, Esq.

Our findings indicate that a large commercial insurer is increasingly covering acupuncture for its beneficiaries. Unlike Medicare Part B, which limits acupuncture coverage to chronic low back pain, ...

A new study published in Clinical & Experimental Ophthalmology found that faricimab was effective in treating patients with neovascular age-related macular degeneration (nAMD) who had not previously ...

Susan Vadaparampil, PhD, MPH, of Moffitt Cancer Center, concludes her conversation with The American Journal of Managed Care® at last month’s Institute for Value-Based Medicine ® event in Tampa, ...